CHEK2 and breast cancer: Results from BCAC demonstrated that CHEK2 variants were associated with all breast cancer subtypes except triple negative.18 Analogously, we demonstrated an association between carrying CHEK2 1100delC and development of ER-positive CBC, but not ER-negative CBC.